Delivery Order SPE2DB20D3101-SPE2DB25FRLT6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $42,739.50 to AmerisourceBergen Drug Corp for supply of Botox 200 unit vials, with a completion date of August 20, 2025. This competitive award, issued on July 30, 2025, carries no set-aside designation and employs firm fixed pricing terms. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,595.66 delivery order to AmerisourceBergen Drug Corp for Botox Cosmetic 100 Unit vials under a firm fixed-price contract with an ultimate completion date of January 15, 2026. This non-set-aside competitive award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at the...
- The Defense Logistics Agency awarded a $12,045.00 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX on August 1, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $3,613.50 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials on August 8, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a $3,419.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox, with a completion date of June 24, 2025. This is a non-set-aside competitive award executed as a child contract under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a $3,574.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Botox Cosmetic 100-unit vials, with an ultimate completion date of September 8, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $36,135 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, with an ultimate completion date of August 28, 2025. This non-set-aside contract was competitively awarded on August 7, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $3,419.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials, with an ultimate completion date of August 4, 2025. This is a non-set-aside contract awarded competitively to the pharmaceutical distributor's Corporate Office division, with performance occurring at the company's headquarters in Conshohocken, Pennsylvania. The delivery order represents a relatively modest transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $15,056.25 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox on August 4, 2025, with an ultimate completion date of August 25, 2025. This competitive award utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRLT6Delivery Order
The Defense Logistics Agency awarded a $42,739.50 delivery order to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of June 23, 2025. This non-set-aside contract employs firm fixed price terms and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal healthcare procurement needs. This delivery order is part of AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (contract number SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for the Defense Health Agency and other federal healthcare systems. The prime contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The current Botox order exemplifies the specialized medical commodities provided through this vehicle, which encompasses brand-name drugs, generic medications, vaccines, and other critical healthcare supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.7k | 5/30/25 |